Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-27 @ 9:58 AM
Study NCT ID:
NCT05378867
Status:
UNKNOWN
Last Update Posted:
2022-05-18
First Post:
2022-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Assessing the Interchangeability Between TRS003 and Bevacizumab® For CRC
Sponsor:
Zhejiang Teruisi Pharmaceutical Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-04-21
First Submit QC Date:
None
Study First Post Date:
2022-05-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-12
Last Update Post Date:
2022-05-18
Last Update Post Date Type:
ACTUAL